Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
NYSE:EHC
EHC Stock Chart & Stats
$106.39
$0.72(0.79%)
At close: 4:00 PM EST
$106.39
$0.72(0.79%)
Day’s Range― - ―
52-Week Range$87.85 - $127.99
Previous CloseN/A
Volume95.02K
Average Volume (3M)811.29K
Market Cap
$10.70B
Enterprise Value$16.34B
Total Cash (Recent Filing)$48.70M
Total Debt (Recent Filing)$2.66B
Price to Earnings (P/E)20.1
Beta0.59
Next Earnings
Feb 11, 2026EPS Estimate
1.3Next Dividend Ex-DateN/A
Dividend Yield0.66%
Share Statistics
EPS (TTM)1.23
Shares Outstanding100,615,974
10 Day Avg. Volume1,185,898
30 Day Avg. Volume811,286
Financial Highlights & Ratios
PEG Ratio0.72
Price to Book (P/B)4.46
Price to Sales (P/S)1.72
P/FCF Ratio25.61
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue2.82
Enterprise Value/Gross Profit6.44
Enterprise Value/Ebitda12.17
Forecast
1Y Price Target
$145.00Price Target Upside36.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)5.31
Revenue Forecast (FY)$5.93B
Bulls Say, Bears Say
Bulls Say
Bed ExpansionsEncompass once again increased guidance for bed expansions, raising 2025 expectations from 110 to 127 bed additions.
Long-Term Growth OutlookIncremental confidence in both the durability of Encompass’s long-term growth outlook and the free cash flow growth flywheel, which is fueling both growth investment and share repurchases.
Bears Say
Discharge GrowthRelatively soft discharge growth compared to recent trends, on a challenging prior-year comp, sent shares down 7%.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $87.85 and its highest was $127.99 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $10.70B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Feb 11, 2026 which is in 51 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Oct 29, 2025. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.199 by $0.031.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.66%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.3.
How many shares outstanding does Encompass Health have?
Encompass Health has 100,615,974 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.23 in its last earnings report, beating expectations of $1.199. Following the earnings report the stock price went down -7.021%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$145.00 (36.29% Upside)
$145.00 (36.29% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 244.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.0%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
14.11%
12-Months-Change
Fundamentals
Return on Equity
24.94%
Trailing 12-Months
Asset Growth
6.31%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
EHC Company Deck
EHC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with significant revenue growth, increased guidance, and successful strategic initiatives such as new hospital openings and an ERP system conversion. However, there were challenges in volume growth due to strong prior year comps and increased tax expenses.View all EHC earnings summariesEHC Stock 12 Month Forecast
Average Price Target
$145.00
▲(36.29% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―
Ownership Overview
1.24% Insiders
30.78% Mutual Funds
20.66% Other Institutional Investors
24.79% Public Companies and
Individual Investors